Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2,850,581
-
Total 13F shares
-
1,308,264
-
Share change
-
-1,210,640
-
Total reported value
-
$415,048
-
Price per share
-
$0.31
-
Number of holders
-
9
-
Value change
-
-$388,177
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q3 2023
As of 30 Sep 2023,
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,308,264 shares.
The largest 9 holders included
ARMISTICE CAPITAL, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, NATIONAL BANK OF CANADA /FI/, OSAIC HOLDINGS, INC., New England Capital Financial Advisors LLC, Federation des caisses Desjardins du Quebec, and MORGAN STANLEY.
This page lists
9
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.